A STUDY ON THE EVALUATION OF CARDIAC DYSFUNCTION AMONG OLDER PEOPLE ATTENDING HOSPITAL FOR APPARENTLY NON-CARDIAC PROBLEM

Main Article Content

Dr Shamik Banerjee
Dr Bipul Barman

Keywords

....

Abstract

An unprecedented increase in human longevity was one of the most spectacular events of 20th century. The United Nations held its second General Assembly on aging in Madrid, in April 02 and International Plan of Action on aging 2002 was adopted. The health component of this declaration was based on the document “Active aging: A policy frame work” prepared by WHO.2


In the year 2002 there were an estimated 605 million old person in the world of which 400 million were living in low income countries. Between 2000 and 2030, the number of older adults worldwide is expected to increase from 420 to 974 million. Cardiovascular disease is the most frequent diagnosis in elderly people and is the leading cause of death in both men and women 1 older than 65 years of age. The profile of these common cardiovascular diseases differs in older patients from that in younger patients. Systolic, but not diastolic, blood pressure increases with aging, resulting in increased pulse pressure. Systolic hypertension becomes a stronger predictor of cardiovascular events, especially in women. Heart failure with preserved systolic function becomes more common at older ages and is more common in women. Coronary artery disease (CAD) is more likely to involve multiple vessels and left main artery disease and is equally likely in women as in men older than 65 years of age. Equal numbers of older men and women present with acute myocardial infarction (MI) until age 80, after which more women present
Abstract 0 | PDF Downloads 0

References

1. Libby: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 8th ed. Park; textbook on community medicine,20th ed
2. Centers for Disease Control and Prevention : MMWR Series on Public Health and Aging. MMWR 2003; 52:101-106.
3. National Academy on an Aging Society : Alzheimer's Disease and Dementia. A Growing Challenge, Washington, DC, National Academy on an Aging Society, 2000.
4. Lakatta E, Levy D: Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part II: The aging heart in health: Links to heart disease. Circulation 2003; 107:346-354.
5. Lakatta E, Levy D: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: Aging arteries a “set up” for vascular disease. Circulation 2003; 107:139-146.
6. Kass D: Age-related changes in ventricular-arterial coupling: Pathophysiologic implications. Heart Fail Rev 2002; 7:51-62.
7. Lakatta E: Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part III: Cellular and molecular clues to heart and arterial aging. Circulation 2003; 107:490-497.
8. Zhou Y, Lakatta E, Xiao R: Age-associated alterations in calcium current and its modulation in cardiac myocytes. Drugs Aging 1998; 13:159-171.
9. Wilkerson W, Sane D: Aging and thrombosis. Semin Thromb Hemost 2002; 28:555-568.
10. Seals D, Esler M: Human ageing and the sympathoadrenal system. J Physiol 2000; 528:407-417.
11. Rehman H, Masson E: Neuroendocrinology of ageing. Age Ageing 2001; 30:279-287.
12. Kaasinen V, Rinne J: Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease. Neurosci Biobehav Rev 2002; 26:785-793.
13. Hess P, Fleg J, Mirza Z, et al: Effects of normal aging on left ventricular lusitropic, inotropic, and chronotropic responses to dobutamine. J Am Coll Cardiol 2006; 47:1440-1447.
14. Walford R, Mock D, Verdery R, MacCallum T: Calorie restriction in biosphere 2: Alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol A Biol Sci Med Sci 2002; 57:B211-B224.